NCT01991860 - US Phase III Study of APD421 in PONV | Biotech Hunter

Enrollment

364

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions

PONV

Interventions

DRUG

APD421- Amisulpride for IV injection

APD421 ( Amisulpride) at 5mg given by single intravenous (IV) administration, by slow push over one minute, at induction of anaesthesia

DRUG

Placebo

Matching Placebo given by single intravenous (IV) administration, by slow push over one minute, at induction of anaesthesia

Trial Locations (1)

Duke, Durham